Gaudium IVF and Women Health Ltd
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]
- Market Cap ₹ 834 Cr.
- Current Price ₹ 115
- High / Low ₹ 164 / 69.2
- Stock P/E 38.6
- Book Value ₹ 20.5
- Dividend Yield 0.00 %
- ROCE 27.4 %
- ROE 22.9 %
- Face Value ₹ 5.00
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.1%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 217 days.
- Working capital days have increased from 49.1 days to 124 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|
| 44 | 46 | 59 | 72 | 73 | |
| 24 | 27 | 31 | 37 | 40 | |
| Operating Profit | 20 | 19 | 28 | 35 | 33 |
| OPM % | 45% | 41% | 48% | 48% | 45% |
| 0 | 0 | 0 | 0 | 2 | |
| Interest | 0 | 1 | 2 | 3 | 3 |
| Depreciation | 1 | 2 | 2 | 2 | 2 |
| Profit before tax | 18 | 16 | 25 | 29 | 29 |
| Tax % | 26% | 38% | 25% | 24% | |
| 13 | 10 | 19 | 22 | 22 | |
| EPS in Rs | 133.91 | 100.28 | 3.03 | 3.06 | 3.28 |
| Dividend Payout % | 48% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 18% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 19% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 32% |
| Last Year: | 23% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.99 | 0.99 | 31 | 36 |
| Reserves | 22 | 26 | 15 | 113 |
| 10 | 17 | 21 | 23 | |
| 2 | 7 | 9 | 7 | |
| Total Liabilities | 35 | 51 | 75 | 179 |
| 16 | 18 | 18 | 27 | |
| CWIP | 0 | 0 | 7 | 0 |
| Investments | 1 | 1 | 6 | 6 |
| 18 | 31 | 44 | 145 | |
| Total Assets | 35 | 51 | 75 | 179 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 24 | 3 | 8 | 7 | |
| -14 | -5 | -15 | -86 | |
| 4 | -1 | 2 | 80 | |
| Net Cash Flow | 13 | -3 | -5 | 2 |
| Free Cash Flow | 11 | 1 | -0 | 3 |
| CFO/OP | 145% | 28% | 46% | 53% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 7 | 108 | 146 | 217 |
| Inventory Days | 101 | 141 | 170 | 177 |
| Days Payable | 83 | 85 | 99 | 217 |
| Cash Conversion Cycle | 26 | 164 | 218 | 176 |
| Working Capital Days | -54 | -22 | 46 | 124 |
| ROCE % | 44% | 48% | 27% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Average Revenue Per Patient (ARPP) INR Lakhs |
|
|||
| IVF Success Rate (First Attempt) % |
||||
| IVF Treatment Revenue Share % |
||||
| Number of Embryologists count |
||||
| Number of OPU (Ovum Pick-Ups) count |
||||
| International Patients Share % |
||||
| Number of Hubs count |
||||
| Number of Spokes count |
||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Intimation of Post Dispatch Newspaper Advertisement for the Notice of 11th Annual General Meeting and E-Voting Information
-
Weblink Letter To Shareholders - Pursuant To Regulation 36(1)(B) Of SEBI (LODR) Regulations, 2015
- 11th AGM on September 28, 2026; FY2025-26 annual report and e-voting details shared.
- Reg. 34 (1) Annual Report.
-
Notice Of 11Th Annual General Meeting Of The Company
- 11th AGM on September 28, 2026; approve FY26 financials, director remuneration, secretarial auditor appointment.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Gaudium IVF and Women Health Limited informed about copy of newspaper publication regarding Pre-AGM Notice of 11th Annual General Meeting to be held on Monday, …
Concalls
-
Aug 2026Transcript PPT REC
-
Aug 2026TranscriptAI SummaryPPT
-
May 2026Transcript PPT REC
Business Profile[1][2]
The company operates in the Assisted Reproductive Technology (ART) and IVF segment in India, following a hub-and-spoke model across 30+ locations (7 hubs and 28 spokes). It also runs a 15-bed day-care hospital in Janakpuri (Delhi NCR) and operates an in-house pharmacy through its wholly owned subsidiary, Gaudium International Pvt. Ltd.